BioMarin Pharmaceutical (BMRN ... In a report issued on February 22, RBC Capital also maintained a Hold rating on the stock with a $100.00 price target. See today’s best-performing stocks ...

Dennis Slamon, Board Member at Biomarin Pharmaceutical BMRN, reported a large exercise of company stock options on March 20, according to a new SEC filing. What Happened: Disclosed in a Form 4 ...

BIOMARIN PHARMACEUTICAL INC (BMRN) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 57% based on the firm’s underlying fundamentals and the ...

The third marvelous growth stock that's begging to be bought in the young Nasdaq bull market is specialty biotech company ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

“The highly correlated stock prices of its holdings belie its apparent diversification across many sectors.” Wood has defended herself from Morningstar’s criticism. “I do know there are ...

Learn about our editorial policies If you owned stock before the time of the internet and online brokerages, there's a very good chance that you had a stock certificate to prove it. When a company ...

Artificial intelligence is the future of technology and a hot stock option — here's everything you need to know about investing in AI. General Electric posted its final earnings as a combined ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...